Copyright
©The Author(s) 2016.
World J Transplant. Dec 24, 2016; 6(4): 729-735
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.729
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.729
Figure 1 Patients’ Epstein-Barr virus serostatus pre-heart transplant, post-transplant Epstein-Barr virus viral load as determined by whole blood polymerase chain reaction and incidence of post-transplant lymphoproliferative disorder for the entire cohort.
EBV: Epstein-Barr virus; PTLD: Post-transplant lymphoproliferative disorder; PCR: Polymerase chain reaction.
- Citation: Das B, Morrow R, Huang R, Fixler D. Persistent Epstein-Barr viral load in Epstein-Barr viral naïve pediatric heart transplant recipients: Risk of late-onset post-transplant lymphoproliferative disease. World J Transplant 2016; 6(4): 729-735
- URL: https://www.wjgnet.com/2220-3230/full/v6/i4/729.htm
- DOI: https://dx.doi.org/10.5500/wjt.v6.i4.729